FineMark National Bank & Trust’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
EIP
FineMark National Bank & Trust's CLB Position: Q3 2018 in Review
FineMark National Bank & Trust sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 3,336 shares — an estimated $421K sold.
FineMark National Bank & Trust first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $663K in Q4 2015. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.
- FineMark National Bank & Trust reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
- FineMark National Bank & Trust sold 3,336 Core Laboratories shares in Q3 2018, an estimated $421K.
- FineMark National Bank & Trust first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
- FineMark National Bank & Trust's Core Laboratories position peaked at $663K in Q4 2015.
- 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.
Based on FineMark National Bank & Trust's 13F filing for Q3 2018, filed 2 Nov 2018.